Publication | Open Access
Low-Dose Intravitreal Methotrexate for Proliferative Vitreoretinopathy
19
Citations
27
References
2023
Year
Low-dose MTX (200 μg/0.05 mL) during and after PVR surgery resulted in good rates of retinal reattachment and visual acuity recovery. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2023;54(3):139-146.]</b>.
| Year | Citations | |
|---|---|---|
Page 1
Page 1